AI is cutting clinical trial timelines by up to 50% while improving patient selection, biomarker identification and ...
Accelerating clinical adoption highlighted by GE HealthCare’s latest FDA clearance for AI-guided radiation planning, Canon ...
Collaboration combines molecular biomarkers with AI-enabled digital assessments to support more precise characterization of neurodegenerative disease Amprion, a global leader advancing diagnosis of ...
Antibody-drug conjugate (ADC) after ADC: Predicting survival in patients with HER2-low metastatic breast cancer with lung metastasis using artificial intelligence (AI) and radiomics. This is an ASCO ...
WALTHAM, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven advanced therapy CDMO and gene editing services partner, today announced data from presentations at the American ...
IBM Corp. is partnering with the European Space Agency to create an artificial intelligence system that will keep tabs on climate change and other global issues, such as water scarcity, in real time ...
Conversation is a well-established diagnostic tool. For disorders such as Parkinson’s disease and amyotrophic lateral sclerosis, patient assessments include interviews during which observations are ...
Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, and Modality.AI, a leader in AI-enabled multimodal clinical assessments, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results